Immunomodulating versus high-protein oral preoperative supplement in surgical patients - A two-center, prospective, randomized clinical trial.

MLA

Klek, Stanislaw, et al. “Immunomodulating versus High-Protein Oral Preoperative Supplement in Surgical Patients - A Two-Center, Prospective, Randomized Clinical Trial.” Nutrition (Burbank, Los Angeles County, Calif.), vol. 101, Sept. 2022, p. 111701. EBSCOhost, https://doi.org/10.1016/j.nut.2022.111701.

APA

Klek, S., Kret, K., Choruz, R., Pisarska-Adamczyk, M., Salowka, J., Cegielny, T., Welanyk, J., Wilczek, M., & Pedziwiatr, M. (2022). Immunomodulating versus high-protein oral preoperative supplement in surgical patients - A two-center, prospective, randomized clinical trial. Nutrition (Burbank, Los Angeles County, Calif.), 101, 111701. https://doi.org/10.1016/j.nut.2022.111701

Chicago

Klek, Stanislaw, Kamila Kret, Ryszard Choruz, Magdalena Pisarska-Adamczyk, Jerzy Salowka, Tomasz Cegielny, Joanna Welanyk, Mariusz Wilczek, and Michal Pedziwiatr. 2022. “Immunomodulating versus High-Protein Oral Preoperative Supplement in Surgical Patients - A Two-Center, Prospective, Randomized Clinical Trial.” Nutrition (Burbank, Los Angeles County, Calif.) 101 (September): 111701. doi:10.1016/j.nut.2022.111701.